DD139858A5 - Verfahren zur herstellung von pleuromutilinglycosidderivaten - Google Patents

Verfahren zur herstellung von pleuromutilinglycosidderivaten Download PDF

Info

Publication number
DD139858A5
DD139858A5 DD78209624A DD20962478A DD139858A5 DD 139858 A5 DD139858 A5 DD 139858A5 DD 78209624 A DD78209624 A DD 78209624A DD 20962478 A DD20962478 A DD 20962478A DD 139858 A5 DD139858 A5 DD 139858A5
Authority
DD
German Democratic Republic
Prior art keywords
deoxy
thioacetoxy
acetyl
mutilin
item
Prior art date
Application number
DD78209624A
Other languages
German (de)
English (en)
Inventor
Ramakrishnan Nagarajan
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of DD139858A5 publication Critical patent/DD139858A5/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/18Acyclic radicals, substituted by carbocyclic rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Communicable Diseases (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Saccharide Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DD78209624A 1977-12-08 1978-12-08 Verfahren zur herstellung von pleuromutilinglycosidderivaten DD139858A5 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US05/858,507 US4130709A (en) 1977-12-08 1977-12-08 Pleuromutilin glycoside derivatives

Publications (1)

Publication Number Publication Date
DD139858A5 true DD139858A5 (de) 1980-01-23

Family

ID=25328471

Family Applications (1)

Application Number Title Priority Date Filing Date
DD78209624A DD139858A5 (de) 1977-12-08 1978-12-08 Verfahren zur herstellung von pleuromutilinglycosidderivaten

Country Status (28)

Country Link
US (1) US4130709A (fr)
EP (1) EP0002588B1 (fr)
JP (1) JPS5498751A (fr)
AT (1) AT362065B (fr)
AU (1) AU524665B2 (fr)
BE (1) BE872489A (fr)
CA (1) CA1109866A (fr)
CH (1) CH639103A5 (fr)
CS (2) CS219344B2 (fr)
DD (1) DD139858A5 (fr)
DE (1) DE2862226D1 (fr)
DK (1) DK539578A (fr)
ES (1) ES475854A1 (fr)
FI (1) FI783709A (fr)
FR (1) FR2411205A1 (fr)
GB (1) GB2009738B (fr)
GR (1) GR72774B (fr)
HU (1) HU181429B (fr)
IE (1) IE47533B1 (fr)
IL (1) IL56115A (fr)
IT (1) IT1160316B (fr)
LU (1) LU80619A1 (fr)
PL (1) PL123850B1 (fr)
PT (1) PT68857A (fr)
RO (3) RO84426B (fr)
SU (1) SU902666A3 (fr)
YU (1) YU281878A (fr)
ZA (1) ZA786872B (fr)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA80175B (en) * 1979-01-12 1981-08-26 Sandoz Ltd New pleuromutilin derivatives, their production and use
US5041534A (en) * 1983-03-22 1991-08-20 Merrell Dow Pharmaceuticals Process for preparing antibiotic L 17054
FR2551442B1 (fr) * 1983-09-05 1987-04-30 Centre Nat Rech Scient Nouveaux derives furaniques, leur preparation et leur application
US5077398A (en) * 1986-11-18 1991-12-31 Merck & Co., Inc. Process for isolation of avermectin B1 components with improved purity and subsequent isolaton of B2 components
US5696096A (en) * 1990-09-28 1997-12-09 Bristol-Myers Squibb Company Pradimicin derivatives
US5843908A (en) * 1990-09-28 1998-12-01 Bristol-Myers Squibb Company Pradimicins l and fl, and derivatives thereof
AT400674B (de) * 1991-07-24 1996-02-26 Biochemie Gmbh Pharmazeutische pleuromutilin-zubereitung
JP3816570B2 (ja) * 1996-02-16 2006-08-30 塩水港精糖株式会社 アシル化剤
GB9614017D0 (en) * 1996-07-04 1996-09-04 Biochemie Gmbh Organic compounds
UY25225A1 (es) 1997-10-29 2000-12-29 Smithkline Beecham Plc Derivados de pleuromutilina utiles como agentes antimicrobianos
GB0218578D0 (en) * 2002-08-09 2002-09-18 Glaxo Group Ltd Novel method
GB0308114D0 (en) * 2003-04-08 2003-05-14 Glaxo Group Ltd Novel compounds
WO2005023257A1 (fr) 2003-09-03 2005-03-17 Glaxo Group Limited Procede, sels, compositions et utilisation
US6838576B1 (en) 2003-10-23 2005-01-04 3M Innovative Properties Company Process for preparing functional group-containing olefinic compounds
US20140162965A1 (en) 2004-08-25 2014-06-12 Aegis Therapeutics, Inc. Compositions for oral drug administration
US20060046962A1 (en) 2004-08-25 2006-03-02 Aegis Therapeutics Llc Absorption enhancers for drug administration
US8268791B2 (en) * 2004-08-25 2012-09-18 Aegis Therapeutics, Llc. Alkylglycoside compositions for drug administration
US9895444B2 (en) 2004-08-25 2018-02-20 Aegis Therapeutics, Llc Compositions for drug administration
GB0513058D0 (en) * 2005-06-27 2005-08-03 Sandoz Ag Organic compounds
US8226949B2 (en) 2006-06-23 2012-07-24 Aegis Therapeutics Llc Stabilizing alkylglycoside compositions and methods thereof
US7998927B2 (en) * 2006-06-23 2011-08-16 Aegis Therapeutics, Llc Stabilizing alkylglycoside compositions and methods thereof
US20090326193A1 (en) * 2006-06-23 2009-12-31 Aegis Therapeutics Llc Stabilizing alkylglycoside compositions and methods thereof
US8084022B2 (en) 2006-06-23 2011-12-27 Aegis Therapeutics, Llc Stabilizing alkylglycoside compositions and methods thereof
US8173594B2 (en) * 2006-06-23 2012-05-08 Aegis Therapeutics, Llc Stabilizing alkylglycoside compositions and methods thereof
EP1972618A1 (fr) 2007-03-20 2008-09-24 Nabriva Therapeutics AG Dérivés de pleuromutilin pour le traitement des maladies médiées par des microbes
EP2271347B1 (fr) 2008-03-28 2016-05-11 Hale Biopharma Ventures, Llc Administration de compositions de benzodiazépine
US8440631B2 (en) 2008-12-22 2013-05-14 Aegis Therapeutics, Llc Compositions for drug administration
EP3193946A4 (fr) * 2014-09-19 2018-05-23 Emory University Analogues de saccharide et agents pour le diagnostic et la thérapie d'infections bactériennes

Also Published As

Publication number Publication date
BE872489A (fr) 1979-06-05
ZA786872B (en) 1980-08-27
FR2411205A1 (fr) 1979-07-06
RO84426A (fr) 1984-06-21
IL56115A (en) 1984-01-31
HU181429B (en) 1983-07-28
RO80082A (fr) 1983-02-01
AU4216278A (en) 1979-06-14
EP0002588A1 (fr) 1979-06-27
IE782421L (en) 1979-06-08
ES475854A1 (es) 1980-05-16
SU902666A3 (ru) 1982-01-30
EP0002588B1 (fr) 1983-04-06
IL56115A0 (en) 1979-03-12
IT1160316B (it) 1987-03-11
YU281878A (en) 1983-06-30
CH639103A5 (fr) 1983-10-31
PL211492A1 (pl) 1979-11-19
GB2009738A (en) 1979-06-20
RO84425A (fr) 1984-06-21
RO80082B (ro) 1983-01-30
DE2862226D1 (en) 1983-05-11
GR72774B (fr) 1983-12-05
FR2411205B1 (fr) 1981-08-14
RO84425B (ro) 1984-08-30
AT362065B (de) 1981-04-27
PL123850B1 (en) 1982-12-31
AU524665B2 (en) 1982-09-30
CA1109866A (fr) 1981-09-29
US4130709A (en) 1978-12-19
CS219344B2 (en) 1983-03-25
CS219342B2 (en) 1983-03-25
FI783709A (fi) 1979-06-09
DK539578A (da) 1979-07-05
RO84426B (ro) 1984-08-30
JPS5498751A (en) 1979-08-03
IT7830657A0 (it) 1978-12-06
PT68857A (en) 1979-01-01
LU80619A1 (fr) 1979-06-05
GB2009738B (en) 1982-11-10
IE47533B1 (en) 1984-04-18
ATA871578A (de) 1980-09-15

Similar Documents

Publication Publication Date Title
DD139858A5 (de) Verfahren zur herstellung von pleuromutilinglycosidderivaten
EP0091645A1 (fr) Dérivés N-glycosylés d'amides d'acides carboniques, leur méthode de préparation et leur emploi pour influencer le système immunogène
DE2813021C2 (de) Antibiotika KA-6606 I, II, III und IV, diese Antibiotika enthaltende Mittel und Verfahren zur Herstellung dieser Verbindungen
DE2942194C2 (de) Aminoglycoside, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende antibiotische Mittel
DE2411504B2 (de) 6'-Substituierte 6'-Desoxylividomycine B, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel
EP0131181A2 (fr) Dérivés d'anthracyclines, une méthode microbiologique pour leur préparation et leur emploi comme agents cytostatiques
DE2726839A1 (de) 2-deoxystreptamin-aminoglycoside, verfahren zu ihrer herstellung und diese enthaltende arzneimittel
DE2533985C2 (de) Verfahren zur Herstellung von 3'-Desoxyneamin, kanamycin B, ribostamycin, -6'-N-methylkanamycin B und paromamin
DE2364999A1 (de) Verfahren zur dehydroxylierung von aminoglykosid-antibiotika
DE2537375A1 (de) 9,3'',4''-triacylester des antibiotikums sf-837 m tief 1 sowie verfahren zur herstellung derselben
DE3786562T2 (de) 2,6-Dideoxy-2-fluoro-L-talopyranose, Derivate davon und Herstellung dieser Verbindungen.
CH626896A5 (fr)
DE2361159C3 (de) 3'-Desoxy-neamin-Derivate, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel
DE1543203A1 (de) Neue Furanoside und Verfahren zu ihrer Herstellung
DE2014277C3 (de) Verfahren zur Herstellung von Acylderivaten des Antibiotikums T-2636 C
DE2928373C2 (de) Antibiotika KA-7038I bis KA-7038VII, deren Salze, Verfahren zu deren Herstellung und diese Verbindungen enthaltende antibiotische Mittel
DE2437159C2 (de) Mutamicine 1, 2, 4, 5 und 6, Verfahren zu ihrer Herstellung sowie diese Verbindungen enthaltende Arzneimittel
DE2118636A1 (de) 3-Nucleotide von Lincomycin und deren Analogen, Verfahren zu ihrer Herstellung und ihre Verwendung in therapeutischen Präparaten
DE3004178C2 (fr)
DE69029900T2 (de) Pradimicin-Derivate
DE3008649C2 (fr)
DE2855175A1 (de) 6'-epi-fortimicin a- und b-derivate
DE3008631A1 (de) Neue spectinomycin-analoge und verfahren zu ihrer herstellung
DE3116127C2 (de) Verfahren zur Herstellung von 3'-Desoxykanamycin A
DE69217597T2 (de) Antibiotikum LL-E19020 Epsilon und LL-E19029 Epsilon 1